U.S. flag

An official website of the United States government, Department of Justice.

DNA Capacity Enhancement for Backlog Reduction (CEBR) Program

© iStock.com/janiecbros (see reuse policy).

Performance Measures

Performance Reporting at BJA

The Bureau of Justice Assistance (BJA) is required to set clear program goals and collect performance measures data to demonstrate achievement of those goals. All recipients of BJA funding are required to collect and report performance data that demonstrate the results of funded activities. For more information regarding BJA’s performance measures, including performance management and reporting, visit BJA's Performance Measures webpage.

CEBR Performance Reporting

Program-specific information regarding performance reporting, as well as program fact sheets, frequently asked questions, and a complete list of the performance measures collected for the DNA Capacity Enhancement for Backlog Reduction (CEBR) Program, can be found in the CEBR section of the Performance Measures webpage.

CEBR performance measures capture the outcomes and impact of the grant activities and are collected on a semi-annual basis from each CEBR program grantee. While performance measures are not the only way to evaluate a laboratory, these measures allow BJA to assess the performance of a grantee, in terms of turnaround time and backlog, by comparing their performance over time and in comparison with other grantees in the CEBR program. For example, by collecting the baseline turnaround time and backlog measures for each grantee at the beginning of their award period, BJA can assess where each grantee falls with respect to other grantees in the program. Furthermore, BJA can estimate the amount of time it will take the grantee to address their backlogs if their current conditions remain the same.

Below is a summary table of performance measure data obtained in 2022 from active grantees of the FY20 CEBR program. This “snapshot” of data can help BJA, grantee laboratories, and the public better understand how accredited DNA laboratories are currently functioning in the United States. Many factors may impact the reported performance measures in a given reporting period, including, but not limited to, staffing, precautions taken due to COVID-19, supply-chain delays, number of testing requests received by the laboratory, implementation of new DNA technology, financial resources available to the agency, and accreditation standards. As such, performance measures reported by a single laboratory are likely to change from reporting period to reporting period. Therefore, the primary value in reviewing the measures is to better understand how CEBR grantees, as a whole, are performing at this time.

FY 2020 CEBR grantee data table

NOTE: In an effort to normalize the reported backlogs of grantees in the CEBR program, a ratio is calculated using the total backlog divided by the average number of cases completed per month. This ratio can help better compare the operation of laboratories of different sizes (e.g., larger laboratories likely have larger backlogs simply due to their service area, but are also more likely to be able to complete more cases per month than a smaller laboratory). Larger ratios generally indicate laboratories that face more challenges in reducing their backlogs.

Performance Metrics Guidance

Frequently Asked Questions

Date Created: January 27, 2023